SEC Form 4 · accession 0001127602-18-010338

Medtronic plc · MDT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Carol A Surface

Officer — SVP, Chief HR Officer

Period of report

Mar 2, 2018

Accepted (ET)

Mar 6, 2018 · 4:09 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001613103

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Ordinary Shares^F1	Mar 2, 2018	S	12,000	$78.00	D	42,010	D
Ordinary Shares^F2	Mar 5, 2018	S	12,479	$78.36	D	29,531	D
Ordinary Shares	Mar 5, 2018	M	24,719	$57.65	A	54,250	D
Ordinary Shares	Mar 5, 2018	M	22,706	$62.76	A	76,956	D
Ordinary Shares	Mar 5, 2018	M	1,195	$62.76	A	78,151	D
Ordinary Shares	Mar 5, 2018	F	40,338	$79.74	D	37,813	D
Ordinary Shares	holding	—	—		—	1,092	I	401(k)

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$57.65	Mar 5, 2018	M	24,719	D	—	Oct 28, 2023	Ordinary Shares	24,719	8,239	D
Stock Option (Right to Buy)^F4,F5	$62.76	Mar 5, 2018	M	22,706	D	—	Jul 28, 2024	Ordinary Shares	22,706	7,569	D
Stock Option (Right to Buy)^F4,F5	$62.76	Mar 5, 2018	M	1,195	D	—	Jul 28, 2024	Ordinary Shares	1,195	6,374	D

Explanation of responses

F1This balance increased by 140 shares due to exempt transactions such as dividend reinvestment.
F2The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.340 to $78.440, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
F3This option to purchase 32,958 New Medtronic ordinary shares for $57.65 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 32,958 Medtronic common stock shares for $57.65 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F4This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F5This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.